Child's Nervous System

, Volume 22, Issue 8, pp 896–908 | Cite as

Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspects

Special Annual Issue



To review the management of epilepsy in patients with tuberous sclerosis complex (TSC) with an emphasis on surgical aspects, neuropathology, and pathogenesis.


Review of the literature and presentation of the authors’ experience of surgery for refractory epilepsy in patients with TSC.


TSC is a multisystem genetic disorder with variable phenotypic expression. TSC results from a mutation in the TSC1 gene on chromosome 9, which codes for hamartin, or in the TSC 2 gene on chromosome 16 which codes for tuberin. The majority of the patients have TSC as a result of spontaneous genetic mutations while in one-third of the patients, the disorder is inherited in an autosomal dominant manner. Epilepsy is the most common neurological complication, and up to 80–90% of individuals with TSC develop epilepsy at some point in their lifetime. The onset of epilepsy is typically in early childhood. Infantile spasms are a very common early seizure type although partial seizures may occur. Developmental delay, intellectual impairment, autism, behavioral problems, and neuropsychiatric disorders occur commonly in individuals with TSC and may be associated with poorly controlled epilepsy. Antiepileptic drugs are the first-line management for epilepsy but the ketogenic diet, resection of one or more tubers, corpus callosotomy, and vagus nerve stimulation are other therapeutic options for individuals with poorly controlled epilepsy.


Epilepsy surgery Tuberous sclerosis Pathology Treatment Genetics 


  1. 1.
    Aicardi J, Mumford JP, Dumas C, Wood S (1996) Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups. Epilepsia 37:638–642PubMedCrossRefGoogle Scholar
  2. 2.
    Anonymous (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. The European Chromosome 16 Tuberous Sclerosis Consortium. Cell 75:1305–1315Google Scholar
  3. 3.
    Asano E, Chugani DC, Muzik O et al (2000) Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology 54:1976–1984PubMedGoogle Scholar
  4. 4.
    Asano E, Chugani DC, Muzik O et al (2001) Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 57:1269–1277PubMedGoogle Scholar
  5. 5.
    Avellino AM, Berger MS, Rostomily RC, Shaw CM, Ojemann GA (1997) Surgical management and seizure outcome in patients with tuberous sclerosis. J Neurosurg 87:391–396PubMedGoogle Scholar
  6. 6.
    Bebin EM, Kelly PJ, Gomez MR (1993) Surgical treatment for epilepsy in cerebral tuberous sclerosis. Epilepsia 34:651–657PubMedCrossRefGoogle Scholar
  7. 7.
    Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A (2002) Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 125:1247–1255PubMedCrossRefGoogle Scholar
  8. 8.
    Bonnin JM, Rubinstein LJ, Papasozomenos SC, Marangos PJ (1984) Subependymal giant cell astrocytoma. Significance and possible cytogenetic implications of an immunohistochemical study. Acta Neuropathol (Berl) 62:185–193CrossRefGoogle Scholar
  9. 9.
    Burger PC, Scheithauer BW (1994) Tumors of the central nervous system. In: Anonymous (ed) Atlas of tumor pathology, series 3. Armed Forces Institute of Pathology, Washington, DCGoogle Scholar
  10. 10.
    Carbonara C, Longa L, Grosso E et al (1996) Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes Cancer 15:18–25PubMedCrossRefGoogle Scholar
  11. 11.
    Chiron C, Dumas C, Jambaque I, Mumford J, Dulac O (1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 26:389–395PubMedCrossRefGoogle Scholar
  12. 12.
    Chou TM, Chou SM (1989) Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry on the CNS. Clin Neuropathol 8:45–52PubMedGoogle Scholar
  13. 13.
    Chugani DC, Chugani HT, Muzik O et al (1998) Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol 44:858–866PubMedCrossRefGoogle Scholar
  14. 14.
    Curatolo P, Brinchi V (1993) Antenatal diagnosis of tuberous sclerosis. Lancet 341:176–177PubMedGoogle Scholar
  15. 15.
    Curatolo P, Cusmai R, Cortesi F, Chiron C, Jambaque I, Dulac O (1991) Neuropsychiatric aspects of tuberous sclerosis. Ann NY Acad Sci 615:8–16PubMedCrossRefGoogle Scholar
  16. 16.
    Cusmai R, Chiron C, Curatolo P, Dulac O, Tran-Dinh S (1990) Topographic comparative study of magnetic resonance imaging and electroencephalography in 34 children with tuberous sclerosis. Epilepsia 31:747–755PubMedCrossRefGoogle Scholar
  17. 17.
    Ferrer I, Fabregues I, Coll J, Ribalta T, Rives A (1984) Tuberous sclerosis: a Golgi study of cortical tuber. Clin Neuropathol 3:47–51PubMedGoogle Scholar
  18. 18.
    Franz DN, Tudor C, Leonard J et al (2001) Lamotrigine therapy of epilepsy in tuberous sclerosis. Epilepsia 42:935–940PubMedCrossRefGoogle Scholar
  19. 19.
    Fukushima K, Inoue Y, Fujiwara T, Yagi K (2001) Long-term follow-up study of West syndrome associated with tuberous sclerosis. Brain Dev 23:698–704PubMedCrossRefGoogle Scholar
  20. 20.
    Ganji S, Hellman CD (1985) Tuberous sclerosis: long-term follow-up and longitudinal electroencephalographic study. Clin Electroencephalogr 16:219–224PubMedGoogle Scholar
  21. 21.
    Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63:1457–1461PubMedGoogle Scholar
  22. 22.
    Gomez MR (1999) Natural history of cerebral tuberous sclerosis. In: Gomez MR, Sampson JR, Whittemore VH (eds) Tuberous sclerosis complex (Developmental perspectives in psychiatry), 3rd edn. Oxford University Press, New York, pp 29–46Google Scholar
  23. 23.
    Goodman M, Lamm SH, Engel A, Shepherd CW, Houser OW, Gomez MR (1997) Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol 12:85–90PubMedGoogle Scholar
  24. 24.
    Green AJ, Smith M, Yates JR (1994) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6:193–196PubMedCrossRefGoogle Scholar
  25. 25.
    Guerreiro MM, Andermann F, Andermann E et al (1998) Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients. Neurology 51:1263–1269PubMedGoogle Scholar
  26. 26.
    Hamano S, Tanaka M, Mochizuki M, Sugiyama N, Eto Y (2003) Long-term follow-up study of West syndrome: differences of outcome among symptomatic etiologies. J Pediatr 143:231–235PubMedCrossRefGoogle Scholar
  27. 27.
    Hancock E, Osborne JP (1999) Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol 14:71–74PubMedCrossRefGoogle Scholar
  28. 28.
    Harding GF, Wild JM, Robertson KA et al (2000) Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia 41:1420–1431PubMedCrossRefGoogle Scholar
  29. 29.
    Harding GF, Wild JM, Robertson KA, Rietbrock S, Martinez C (2000) Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss. Neurology 55:347–352PubMedCrossRefGoogle Scholar
  30. 30.
    Hirano A, Tuazon R, Zimmerman HM (1968) Neurofibrillary changes, granulovacuolar bodies and argentophilic globules observed in tuberous sclerosis. Acta Neuropathol (Berl) 11:257–261Google Scholar
  31. 31.
    Hirose T, Scheithauer BW, Lopes MB et al (1995) Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study. Acta Neuropathol (Berl) 90:387–399CrossRefGoogle Scholar
  32. 32.
    Hunt A (1993) Development, behaviour and seizures in 300 cases of tuberous sclerosis. J Intellect Disabil Res 37(Pt 1):41–51PubMedGoogle Scholar
  33. 33.
    Huttenlocher PR, Heydemann PT (1984) Fine structure of cortical tubers in tuberous sclerosis: a Golgi study. Ann Neurol 16:595–602PubMedCrossRefGoogle Scholar
  34. 34.
    Jambaque I, Cusmai R, Curatolo P, Cortesi F, Perrot C, Dulac O (1991) Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings. Dev Med Child Neurol 33:698–705PubMedCrossRefGoogle Scholar
  35. 35.
    Jansen FE, Braun KP, van Nieuwenhuizen O et al (2003) Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis. Arch Neurol 60:1580–1584PubMedCrossRefGoogle Scholar
  36. 36.
    Jarrar RG, Buchhalter JR, Raffel C (2004) Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology 62:479–481PubMedGoogle Scholar
  37. 37.
    Johnson MW, Kerfoot C, Bushnell T, Li M, Vinters HV (2001) Hamartin and tuberin expression in human tissues. Mod Pathol 14:202–210PubMedCrossRefGoogle Scholar
  38. 38.
    Joinson C, O’Callaghan FJ, Osborne JP, Martyn C, Harris T, Bolton PF (2003) Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med 33:335–344PubMedCrossRefGoogle Scholar
  39. 39.
    Jozwiak S, Goodman M, Lamm SH (1998) Poor mental development in patients with tuberous sclerosis complex: clinical risk factors. Arch Neurol 55:379–384PubMedCrossRefGoogle Scholar
  40. 40.
    Kagawa K, Chugani DC, Asano E et al (2005) Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). J Child Neurol 20:429–438PubMedCrossRefGoogle Scholar
  41. 41.
    Kawai K, Shimizu H, Yagishita A, Maehara T, Tamagawa K (2004) Clinical outcomes after corpus callosotomy in patients with bihemispheric malformations of cortical development. J Neurosurg 101:7–15PubMedGoogle Scholar
  42. 42.
    Koh S, Jayakar P, Resnick T, Alvarez L, Liit RE, Duchowny M (1999) The localizing value of ictal SPECT in children with tuberous sclerosis complex and refractory partial epilepsy. Epileptic Disord 1:41–46PubMedGoogle Scholar
  43. 43.
    Koh S, Jayakar P, Dunoyer C et al (2000) Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia 41:1206–1213PubMedCrossRefGoogle Scholar
  44. 44.
    Lachhwani DK, Pestana E, Gupta A, Kotagal P, Bingaman W, Wyllie E (2005) Identification of candidates for epilepsy surgery in patients with tuberous sclerosis. Neurology 64:1651–1654PubMedCrossRefGoogle Scholar
  45. 45.
    Lamb RF, Roy C, Diefenbach TJ et al (2000) The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2:281–287PubMedCrossRefGoogle Scholar
  46. 46.
    Lazarowski A, Lubieniecki F, Camarero S et al (2004) Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol 30:102–106PubMedCrossRefGoogle Scholar
  47. 47.
    Miloloza A, Rosner M, Nellist M, Halley D, Bernaschek G, Hengstschlager M (2000) The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum Mol Genet 9:1721–1727PubMedCrossRefGoogle Scholar
  48. 48.
    Mizuguchi M, Ikeda K, Takashima S (2000) Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis. Acta Neuropathol (Berl) 99:503–510CrossRefGoogle Scholar
  49. 49.
    Morimoto K, Mogami H (1986) Sequential CT study of subependymal giant-cell astrocytoma associated with tuberous sclerosis. Case report. J Neurosurg 65:874–877PubMedGoogle Scholar
  50. 50.
    `Nellist M, van Slegtenhorst MA, Goedbloed M, van den Ouweland AM, Halley DJ, van der Sluijs P (1999) Characterization of the cytosolic tuberin–hamartin complex. Tuberin is a cytosolic chaperone for hamartin. J Biol Chem 274:35647–35652PubMedCrossRefGoogle Scholar
  51. 51.
    Nixon JR, Houser OW, Gomez MR, Okazaki H (1989) Cerebral tuberous sclerosis: MR imaging. Radiology 170:869–873PubMedGoogle Scholar
  52. 52.
    Ohtsuka Y, Ohmori I, Oka E (1998) Long-term follow-up of childhood epilepsy associated with tuberous sclerosis. Epilepsia 39:1158–1163PubMedCrossRefGoogle Scholar
  53. 53.
    Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann NY Acad Sci 615:125–127PubMedCrossRefGoogle Scholar
  54. 54.
    Parain D, Penniello MJ, Berquen P, Delangre T, Billard C, Murphy JV (2001) Vagal nerve stimulation in tuberous sclerosis complex patients. Pediatr Neurol 25:213–216PubMedCrossRefGoogle Scholar
  55. 55.
    Plank TL, Logginidou H, Klein-Szanto A, Henske EP (1999) The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol 12:539–545PubMedGoogle Scholar
  56. 56.
    Richardson EP Jr (1991) Pathology of tuberous sclerosis. Neuropathologic aspects. Ann NY Acad Sci 615:128–139PubMedCrossRefGoogle Scholar
  57. 57.
    Rintahaka PJ, Chugani HT (1997) Clinical role of positron emission tomography in children with tuberous sclerosis complex. J Child Neurol 12:42–52PubMedCrossRefGoogle Scholar
  58. 58.
    Roach ES, Williams DP, Laster DW (1987) Magnetic resonance imaging in tuberous sclerosis. Arch Neurol 44:301–303PubMedGoogle Scholar
  59. 59.
    Romanelli P, Verdecchia M, Rodas R, Seri S, Curatolo P (2004) Epilepsy surgery for tuberous sclerosis. Pediatr Neurol 31:239–247PubMedCrossRefGoogle Scholar
  60. 60.
    Sharp D, Robertson DM (1983) Tuberous sclerosis in an infant of 28 weeks gestational age. Can J Neurol Sci 10:59–62PubMedGoogle Scholar
  61. 61.
    Soucek T, Pusch O, Wienecke R, DeClue JE, Hengstschlager M (1997) Role of the tuberous sclerosis gene-2 product in cell cycle control. Loss of the tuberous sclerosis gene-2 induces quiescent cells to enter S phase. J Biol Chem 272:29301–29308PubMedCrossRefGoogle Scholar
  62. 62.
    Szelies B, Herholz K, Heiss WD et al (1983) Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography. J Comput Assist Tomogr 7:946–953PubMedCrossRefGoogle Scholar
  63. 63.
    Takanashi J, Sugita K, Fujii K, Niimi H (1995) MR evaluation of tuberous sclerosis: increased sensitivity with fluid-attenuated inversion recovery and relation to severity of seizures and mental retardation. AJNR Am J Neuroradiol 16:1923–1928PubMedGoogle Scholar
  64. 64.
    Thiele EA (2004) Managing epilepsy in tuberous sclerosis complex. J Child Neurol 19:680–686PubMedGoogle Scholar
  65. 65.
    Van Bogaert L, Paillas JE, Berard-Badier, Payan H (1958) Etude sur la sclerose tubereuse de Bourneville a forme cerebelleuse. Rev Neurol (Paris) 98:673–689Google Scholar
  66. 66.
    van Slegtenhorst M, de Hoogt R, Hermans C et al (1997) Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277:805–808PubMedCrossRefGoogle Scholar
  67. 67.
    van Slegtenhorst M, Nellist M, Nagelkerken B et al (1998) Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum Mol Genet 7:1053–1057PubMedCrossRefGoogle Scholar
  68. 68.
    Weiner HL (2004) Tuberous sclerosis and multiple tubers: localizing the epileptogenic zone. Epilepsia 45(Suppl 4):41–42PubMedCrossRefGoogle Scholar
  69. 69.
    Westmoreland B (1999) The electroencephalogram in tuberous sclerosis. In: Gomez MR, Sampson JR, Whittemore VH (eds) Tuberous sclerosis complex: developmental perspectives in psychiatry, 3rd edn. Oxford University Press, New York, pp 63–74Google Scholar
  70. 70.
    White R, Hua Y, Scheithauer B, Lynch DR, Henske EP, Crino PB (2001) Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers. Ann Neurol 49:67–78PubMedCrossRefGoogle Scholar
  71. 71.
    Wong M, Ess KC, Uhlmann EJ et al (2003) Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model. Ann Neurol 54:251–256PubMedCrossRefGoogle Scholar
  72. 72.
    Yamanouchi H, Jay V, Rutka JT, Takashima S, Becker LE (1997) Evidence of abnormal differentiation in giant cells of tuberous sclerosis. Pediatr Neurol 17:49–53PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Mary B. Connolly
    • 1
    • 4
  • Glenda Hendson
    • 2
  • Paul Steinbok
    • 3
  1. 1.Division of Pediatric Neurology, Department of PediatricsUniversity of British Columbia and British Columbia’s Children’s HospitalVancouverCanada
  2. 2.Division of Anatomic Pathology, Department of PathologyUniversity of British Columbia and British Columbia’s Children’s HospitalVancouverCanada
  3. 3.Division of Pediatric Neurosurgery, Department of SurgeryUniversity of British Columbia and British Columbia’s Children’s HospitalVancouverCanada
  4. 4.Division of NeurologyBC Children’s HospitalVancouverCanada

Personalised recommendations